Could you please expand on the «scientifically documented rarity»? Do you have specific data in mind?
I have little. The best I have is
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine ... for the C4591001 Clinical Trial Group
https://www.nejm.org/doi/full/10.1056/nejmoa2034577
«The incidence of serious adverse events was similar in the vaccine and placebo groups (0.6% and 0.5%, respectively). // This trial and its preliminary report have several limitations. With approximately 19,000 participants per group in the subset of participants with a median follow-up time of 2 months after the second dose, the study has more than 83% probability of detecting at least one adverse event, if the true incidence is 0.01%, but it is not large enough to detect less common adverse events reliably»
For the rest, I hoped to find active monitoring for severe adverse events, but I found only passive monitoring.